510(k) device
Q21
Neurofield, Inc. · Full-Montage Standard Electroencephalograph (GWQ, Class II) · First FDA decision Aug 31, 2023, newest Aug 31, 2023Epilepsy
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "Q21"
MAUDE reports
0
Brand "Q21", since 2015
PubMed studies
4,543
Mentioning "Q21"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Q21
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Q21510(k)
K221959 · Decided Aug 31, 2023 · 422 days after receipt
Device type: Full-Montage Standard Electroencephalograph (GWQ) · Neurology & Neurosurgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Q21", any status and sponsor, newest update first.
- Adjuvant Radiation Therapy With Ifosfamide in Patients With Mixed Mesodermal Tumors of the UterusCompleted
Montefiore Medical CenterAcademic, hospital or other
NCT00231842 · 30 participants · Start Feb 2003 · Primary completion Jul 2011
Device: Radiation Therapy · For: Uterine Cancer
Sites: The Bronx, New York
University of New MexicoAcademic, hospital or other
NCT00277069 · 33 participants · Start May 2000 · Primary completion Mar 2005
Device: Capecitabine · For: Breast; Cancer
Sites: Albuquerque, New Mexico
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Q21", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code GWQ
228 reports: 203 malfunction, 23 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Q21"[tiab]. The summary above synthesizes these.
- Structural basis of Q-dependent antitermination.
Yin Z, Kaelber JT, Ebright RH · Proc Natl Acad Sci U S A · 2019Research Support, N.I.H., Extramural
- 17q12-q21 variants interact with early-life exposures to modify asthma risk in Black children.
Gereige JD, Morin A, Calatroni A, et al. · Clin Exp Allergy · 2022Letter, Research Support, N.I.H., Extramural
- Association between polymorphisms on chromosome 17q12-q21 and rhinovirus-induced interferon responses.
Regis E, Fontanella S, Curtin JA, et al. · J Allergy Clin Immunol · 2024Research Support, Non-U.S. Gov't
- Genotypes in the 17q12-q21 asthma risk locus and early-life viral wheezing illnesses.
Schoettler N, Gebretsadik T, Singh S, et al. · Pediatr Allergy Immunol · 2025Letter
- t(11;18)(q21;q21)-positive transformed MALT lymphoma.
Tan SY, Ye H, Liu H, et al. · Histopathology · 2008Case Reports, Letter
- Familial partial 14 trisomy.
Miller JQ, Willson K, Wyandt H, et al. · J Med Genet · 1979Case Reports
- t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.
Chen W, Miao Y, Wang R, et al. · Oncol Lett · 2016
- Obsessive-Compulsive Disorder and Chromosome 2 Duplication (2q14.2-q21.1).
Sales M, Silva-Dos-Santos A · Prim Care Companion CNS Disord · 2022
- Primary cutaneous marginal zone B-cell lymphoma.
Cho-Vega JH, Vega F, Rassidakis G, et al. · Am J Clin Pathol · 2006Review
- Clinical relevance of molecular aspects in extranodal marginal zone lymphoma: a critical appraisal.
Raderer M, Kiesewetter B, Du MQ · Ther Adv Med Oncol · 2023Review
- Mucosa-associated lymphoid tissue lymphoma: molecular pathogenesis and clinicopathological significance.
Inagaki H · Pathol Int · 2007Research Support, Non-U.S. Gov't, Review
- A t(18;22)(q21;q11) involving IGL/BCL2, A Rare Event in Chronic Lymphocytic Leukemia.
Dowiak A, Tirado CA · J Assoc Genet Technol · 2018
Other devices of this type
Also filed under product code GWQ.
- Neuronaute with IceCap 2 & IceCap 2 SmallBioserenity · 510(k) 2023
- Cadwell Apollo SystemCadwell Industries, Inc. · 510(k) 2020
- Geodesic EEG System Series 100Electrical Geodesics, Incorporated · 510(k) 2004
- EEG with Video, Model Ex-NwExcel Tech. , Ltd. · 510(k) 2001
- Enobio Dx (Enobio Dx 8)Neuroelectrics Barcelona S.L.U. · 510(k) 2026
- New Wave SystemZeto, Inc. · 510(k) 2026
- Flexset SystemZeto, Inc. · 510(k) 2024
- Neuronaute PlusBioserenity Sas · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.